ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
136 hedge funds and large institutions have $396M invested in iTeos Therapeutics in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 47 increasing their positions, 39 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
-7
Holders Change %
-4.9%
% of All Funds
1.99%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
31
Increased
47
Reduced
39
Closed
36
Calls
$2.04M
Puts
$14.1M
Net Calls
-$12M
Net Calls Change
-$16.3M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$24.8M |
| 2 |
EC
2
EcoR1 Capital
San Francisco,
California
|
$12.2M |
| 3 |
3
Renaissance Technologies
New York
|
$7.65M |
| 4 |
4
Citigroup
New York
|
$3.78M |
| 5 |
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$3.12M |
